You are here

  • Home
  • Archive
  • Volume 8, Issue Suppl 3
  • 351 Pembrolizumab plus lenvatinib vs chemotherapy and lenvatinib monotherapy for recurrent/metastatic head and neck squamous cell carcinoma that progressed on platinum therapy and immunotherapy: LEAP-009

Article metrics

Article menu

Download PDFPDF

Regular and young investigator award abstracts
Clinical trials in progress
351 Pembrolizumab plus lenvatinib vs chemotherapy and lenvatinib monotherapy for recurrent/metastatic head and neck squamous cell carcinoma that progressed on platinum therapy and immunotherapy: LEAP-009

 

Online download statistics by month:

Online download statistics by month: November 2020 to June 2025

AbstractFullPdf
Nov 2020109014
Dec 20203407
Jan 20212604
Feb 20215907
Mar 202193018
Apr 20215809
May 20213305
Jun 2021008
Jul 2021009
Aug 2021009
Sep 2021006
Oct 202178027
Nov 202192017
Dec 20215605
Jan 20224009
Feb 202268012
Mar 20228209
Apr 202272010
May 202268015
Jun 2022110013
Jul 20228606
Aug 202296018
Sep 202292011
Oct 20227606
Nov 20227008
Dec 20227204
Jan 202346010
Feb 20238005
Mar 2023112010
Apr 20238607
May 202382013
Jun 20235605
Jul 2023112015
Aug 20237403
Sep 20232804
Oct 20233601
Nov 20234004
Dec 20236807
Jan 20242606
Feb 20244201
Mar 202448049
Apr 202440013
May 20243804
Jun 20244408
Jul 20244205
Aug 20245008
Sep 20242805
Oct 20242604
Nov 202460010
Dec 20246207
Jan 20251808
Feb 2025407
Mar 2025009
Apr 2025005
May 20250020
Jun 2025007
Total29180526